By point mutations we specifically addressed the liprin-α1–mediated interaction with B56γ/PP2A: we have highlighted specific effects of the B56γ-liprin-α1 interaction revealed by disrupting one of several possible expected interactions of the B56 regulatory subunits in MDA-MB-231 cancer cells. This evidence concerns the gene PTPA and cancer.